Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions / Edition 1

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $79.99
Usually ships in 1-2 business days
(Save 55%)
Other sellers (Hardcover)
  • All (4) from $79.99   
  • New (2) from $79.99   
  • Used (2) from $99.95   
Close
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any BN.com coupons and promotions
$79.99
Seller since 2007

Feedback rating:

(17)

Condition:

New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

New
SHRINKWRAPPED SHIPS FROM USA : Description: 228 Pages: Demos Medical Publishing; 1 edition (June 6, 2008): Radiotherapy plays an integral role in cancer treatment. Approximately ... 60% of cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agents with radiotherapy is the latest cutting-edge extension in cancer therapy for radiation oncologists. Read more Show Less

Ships from: Phoenix, AZ

Usually ships in 1-2 business days

  • Canadian
  • International
  • Standard, 48 States
  • Standard (AK, HI)
  • Express, 48 States
  • Express (AK, HI)
$199.20
Seller since 2008

Feedback rating:

(903)

Condition: New
1933864346 Brand New. Exact book as advertised. Delivery in 4-14 business days (not calendar days). We are not able to expedite delivery.

Ships from: Romulus, MI

Usually ships in 1-2 business days

  • Canadian
  • International
  • Standard, 48 States
  • Standard (AK, HI)
Page 1 of 1
Showing All
Close
Sort by

Overview

Radiotherapy plays an integral role in cancer treatment. Approximately 60% of cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agents with radiotherapy is the latest cutting-edge extension in cancer therapy for radiation oncologists.

Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions is an overview of the current state of clinical and pre-clinical research in combining radiotherapy with targeted biological agents to fight cancer. The text provides a general overview of targeted agents, reviews the current clinical trials, and includes a look at the future of this state-of-the-art practice.

This book begins with a general overview of the topic, including an introduction to the subject; the basic science rationale behind the two most important current targeted agents: epidermal growth factor (EGFR) receptors and vascular epithelial growth factor (VEGF) receptors; the dermatologic manifestations of targeted agents; and an introduction to radioimmunotherapy a treatment that has the ability to combine targeted agents directly with radiotherapy. The second half of the book focuses on specific disease sites, including malignant gliomas, head and neck, lung, pancreatic, cervical, and endometrial cancers.

Biologically targeted agents promise to be the next significant breakthrough in cancer therapy. Written by leading experts in the field, Combining Targeted Biological Agents with Radiotherapy is a comprehensive evaluation of the entire field.

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: James G Douglas, MD, MS (Memorial Hospital of Sweetwater County)
Description: This relatively brief work examines the currently available molecular targeting agents and their interactions with irradiation. The basic science and mechanisms underlying the targeted agents are described, followed by discussions of relevant clinical trials organized by organ system.
Purpose: The book was written to "review both the basic science and current clinical status of combining targeted biologic agents with radiotherapy" as stated by the authors. The book for the most part achieves these objectives, which are certainly important concepts for radiation oncologists to grasp.
Audience: The authors do not clearly state their specific audience, but it can be inferred that the book is directed at radiation oncologists and medical oncologists who use combined modality therapy. The authors are experts in the field of molecular targeting and clinical trials.
Features: The initial three chapters describe the basic science concepts that form the basis for the use of biological targeting and describe the various pathways involved in the major signaling pathways surmised to be involved in cellular growth regulation and response to noxious stimuli. The epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) signaling pathways are described in detail, each in a separate chapter. The remainder of the book deals with clinical uses and potential uses as well as deleterious side effects of targeting agents used as single modalities or combined with irradiation and/or cytotoxic agents.
Assessment: The book suffers at times from being overly technical in its descriptions of the various signaling pathways. The presentation in the first three chapters would have been improved by well placed figures that visually showed the pathways and the interactive molecules and gene products. In fact, the most useful figure does not appear until the eighth chapter, and it is of relatively poor quality. The more clinically related chapters do offer comprehensive reviews of current studies and planned studies and are generally well written.
Read More Show Less

Product Details

  • ISBN-13: 9781933864341
  • Publisher: Demos Medical Publishing, LLC
  • Publication date: 6/28/2008
  • Edition number: 1
  • Pages: 226
  • Product dimensions: 7.20 (w) x 10.10 (h) x 0.70 (d)

Meet the Author

William Small, Jr, MD is Professor of Radiation Oncology and Vice-Chairman of the Department of Radiation Oncology at Northwestern University. He is the Associate Medical Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and serves on the editorial board of the American Journal of Hematology/Oncology Review and Cancer News.

Read More Show Less

Table of Contents

Targeted Therapies: Definitions, Limitations, and Future Directions; Epidermal Growth Factor (EGFR) Receptors; Vascular Epithelial Growth Factor (VEGF) Receptors; Dermatologic Manifestations of Targeted Therapies; Dermatologic Manifestations of Targeted Therapies; Radiolabelled Monoclonal Antibody Therapies; Targeted Therapies in Malignant Gliomas; Targeted Therapies in Head and Neck Cancer; Targeted Therapies in Lung Cancer; Targeted Therapies in Pancreatic Cancer; Targeted Therapies in Cervical Cancer; Targeted Therapies in Endometrial Cancer.
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously
Sort by: Showing 1 Customer Reviews
  • Anonymous

    Posted September 25, 2009

    No text was provided for this review.

Sort by: Showing 1 Customer Reviews

If you find inappropriate content, please report it to Barnes & Noble
Why is this product inappropriate?
Comments (optional)